You are here
TGA reforms: A blueprint for TGA's future
The proposed reforms are fundamental to the appropriate operation of the regulatory frameworks that allow therapeutic goods to be supplied in the Australian marketplace and directly relate to that regulatory activity.
As has been the case since 1998, the full cost of regulating therapeutic goods continues to be met by cost recovery from the regulated industry. This operates effectively under the Act through annual negotiations with relevant industry sectors.
In order to deliver the fundamental reforms, a modest increase in the TGA's fees and charges was introduced from 1 July 2012.
Reforms relating to the promotion of therapeutic goods sit outside the TGA and thus resourcing of that project will not be sought through cost recovery.